1 / 18

TOC - Global Epigenetics Market

The epigenetics market to be one of the highest booming markets, and the global market is predicted to grow at a CAGR of 17.11% during the forecast period 2021-2031.<br>

bisreports
Download Presentation

TOC - Global Epigenetics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. res Epigenetics Market - A Global and Regional Analysis Table of Content Attribution: https://pixabay.com/photos/tire-rim-car-mechanic-114259/ Focus on Product, Mechanism, Technology, Application, End User, and Region Analysis and Forecast: 2021-2031 Epigenetics Market November 2021 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. Copyright © 2021 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this Epigenetics Market document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary .......................................................................... 19 Research Methodology ..................................................................... 25 1.Markets ..................................................................................... 30 1.1 Product Definition ............................................................................................ 31 1.1.1 Inclusion and Exclusion ............................................................................. 31 1.2 Market Scope ................................................................................................... 31 1.2.1 Scope of the Study ...................................................................................... 31 1.2.2 Key Questions Answered in the Report .................................................... 32 1.3 Market Overview .............................................................................................. 33 1.3.1 Market Definition ......................................................................................... 33 1.3.2 Emerging Applications of Epigenetics ...................................................... 33 1.3.2.1 DNA Methylation ................................................................................................ 33 1.3.2.2 Histone Modification .......................................................................................... 34 1.3.2.3 RNA Modification ............................................................................................... 35 1.3.3 Market Footprint and Growth Potential, $Million, 2020-2031 ................... 35 1.3.4 Disruption in Global Epigenetics Market Due to COVID-19 ..................... 36 1.3.5 COVID-19 Affecting Supply Chain of Global Epigenetics Market ............ 37 1.3.6 Interruption in Research and Clinical Development and Commercial Operation ............................................................................................... 37 1.3.6.1 Research and Clinical Development .................................................................. 37 1.3.6.2 Commercial Operation ....................................................................................... 38 1.3.7 Navigating Crisis Recovery and Looking to the Future ........................... 38 2.Industry Insights ........................................................................ 39 2.1 Overview ........................................................................................................... 40 2.2 Legal Requirements and Frameworks in Europe .......................................... 41 Epigenetics Market 2.3 Legal Requirements and Frameworks in Asia-Pacific .................................. 41 2.3.1 China ............................................................................................................ 41 2.3.2 Japan ............................................................................................................ 42 2.4 Reimbursement Analysis ................................................................................ 42 3 All rights reserved at BIS Research Inc.

  4. Iceberg Analysis – Global Epigenetics Market .............................................. 43 3.Market Dynamics ....................................................................... 45 2.5 3.1 Overview ........................................................................................................... 46 3.2 Impact Analysis ............................................................................................... 46 3.3 Market Drivers .................................................................................................. 47 3.3.1 Epigenetics Inclined by Rising Prevalence of Cancer ............................. 47 3.3.2 Strategic Initiatives by Key Market Players ............................................... 48 3.3.3 Increasing Government Initiatives in the Field of Epigenetics ................ 49 3.4 Market Restraints ............................................................................................. 50 3.4.1 High Cost of Instruments ............................................................................ 50 3.4.2 Dearth of Skilled Professionals in Epigenetic Research ......................... 51 3.5 Market Opportunities ....................................................................................... 52 3.5.1 Technological Advancement Toward Innovation in Epigenetics ............ 52 3.5.1.1 Epigenetics & ChIL-Alternative to ChIP-Seq ..................................................... 52 3.5.1.2 Epigenetic Time of Flight (EpiTOF) ................................................................... 52 3.5.2 4.Competitive Landscape ............................................................. 54 Expanding Epigenetic Applications in Non-Oncology Diseases ............ 53 4.1 Overview ........................................................................................................... 55 4.2 Synergistic Activities ...................................................................................... 55 4.3 Product Launches ........................................................................................... 56 4.4 Product Approvals ........................................................................................... 57 4.5 Mergers and Acquisitions ............................................................................... 58 4.6 Other Business Activities ............................................................................... 58 4.7 Market Share Analysis, 2019-2020 ................................................................. 59 4.8 Growth Share Analysis (Company) ................................................................ 61 Growth Share Analysis (Technology) ............................................................ 62 5.Products, $Million, 2020-2031 .................................................... 64 4.9 Epigenetics Market 5.1 Overview ........................................................................................................... 65 5.2 Consumables ................................................................................................... 66 5.2.1 Kits and Assays ........................................................................................... 67 4 All rights reserved at BIS Research Inc.

  5. 5.2.2 Reagents and Enzymes .............................................................................. 69 5.2.3 Other Consumables .................................................................................... 70 5.3 Instruments ...................................................................................................... 71 Software ........................................................................................................... 72 6.Mechanism ................................................................................ 74 5.4 6.1 Overview ........................................................................................................... 75 6.2 DNA Methylation .............................................................................................. 76 6.3 Histone Modification ....................................................................................... 77 6.4 RNA Modification ............................................................................................. 78 Other Mechanisms ........................................................................................... 79 7.Technology ................................................................................ 80 6.5 7.1 Overview ........................................................................................................... 81 7.2 Polymerase Chain Reaction (PCR) ................................................................. 83 7.2.1.1 Real-Time PCR (RT-PCR) ................................................................................. 84 7.2.1.2 Digital PCR (dPCR) ........................................................................................... 85 7.2.2 Sequencing .................................................................................................. 87 7.2.2.1 Next-Generation Sequencing (NGS) ................................................................. 88 7.2.2.2 Traditional Sequencing (Sanger Sequencing) ................................................... 89 7.3 Microarray ........................................................................................................ 90 Other Technologies (MS, Flow Cytometry) .................................................... 92 8.Application ................................................................................ 93 7.4 8.1 Overview ........................................................................................................... 94 8.2 Oncology .......................................................................................................... 95 8.2.1 Clinical Application in Oncology ................................................................ 96 8.2.2 Translational Research Application in Oncology ..................................... 97 8.3 Metabolic Diseases .......................................................................................... 98 8.3.1 Clinical Application in Metabolic Diseases ............................................... 99 Epigenetics Market 8.3.2 Translational Research Application in Metabolic Diseases .................. 100 8.4 Immunology ................................................................................................... 101 8.4.1 Clinical Application in Immunology ......................................................... 102 5 All rights reserved at BIS Research Inc.

  6. 8.4.2 Translational Research Application in Immunology .............................. 102 8.5 Cardiovascular Diseases .............................................................................. 103 8.5.1 Clinical Application in Cardiovascular Diseases .................................... 104 8.5.2 Translational Research Application in Cardiovascular Diseases ......... 106 8.6 Other Applications ......................................................................................... 107 8.6.1 Clinical Application in Other .................................................................... 107 8.6.2 9.End User .................................................................................. 110 Translational Research Application ......................................................... 108 9.1 Overview ......................................................................................................... 111 9.2 Pharmaceutical and Biotechnology Companies ......................................... 112 9.3 Academic and Research Institutions ........................................................... 113 9.4 Contract Research Organizations (CROs) ................................................... 114 Other End Users ............................................................................................ 115 10.Region ..................................................................................... 116 9.5 10.1Overview ......................................................................................................... 117 10.2North America ................................................................................................ 121 10.2.1 U.S. ............................................................................................................. 123 10.2.2 Canada ....................................................................................................... 124 10.3Europe ............................................................................................................ 127 10.3.1 Germany ..................................................................................................... 129 10.3.2 France ......................................................................................................... 130 10.3.3 U.K. ............................................................................................................. 131 10.3.4 Italy ............................................................................................................. 132 10.3.5 Spain ........................................................................................................... 133 10.3.6 Rest-of-Europe........................................................................................... 134 10.4Asia-Pacific .................................................................................................... 136 10.4.1 China .......................................................................................................... 138 Epigenetics Market 10.4.2 India ............................................................................................................ 139 10.4.3 Japan .......................................................................................................... 140 10.4.4 South Korea ............................................................................................... 141 6 All rights reserved at BIS Research Inc.

  7. 10.4.5 Australia ..................................................................................................... 142 10.4.6 Rest-of-Asia-Pacific (RoAPAC) ................................................................ 143 10.5Latin America ................................................................................................. 144 10.5.1 Brazil ........................................................................................................... 146 10.5.2 Mexico ........................................................................................................ 147 10.5.3 Rest-of-Latin America (RoLA) .................................................................. 148 10.6Rest-of-the-World .......................................................................................... 149 11. Company Profiles .................................................................... 150 11.1Overview ......................................................................................................... 151 11.2Thermo Fisher Scientific Inc. ........................................................................ 152 11.2.1 Company Overview ................................................................................... 152 11.2.2 Role of Thermo Fisher Scientific Inc. in the Global Epigenetics Market ................................................................................................... 152 11.2.3 Financials ................................................................................................... 153 11.2.4 Key Insights About Financial Health of the Company ........................... 155 11.2.5 SWOT Analysis .......................................................................................... 156 11.3QIAGEN N.V. ................................................................................................... 157 11.3.1 Company Overview ................................................................................... 157 11.3.2 Role of QIAGEN N.V. in the Global Epigenetics Market ......................... 157 11.3.3 Financials ................................................................................................... 159 11.3.4 Key Insights About Financial Health of the Company ........................... 161 11.3.5 SWOT Analysis .......................................................................................... 162 11.4F. Hoffmann-La Roche Ltd. ........................................................................... 163 11.4.1 Company Overview ................................................................................... 163 11.4.2 Role of F. Hoffmann-La Roche Ltd. in the Global Epigenetics Market .............................................................................................................. 163 11.4.3 Financials ................................................................................................... 165 Epigenetics Market 11.4.4 Key Insights About Financial Health of the Company ........................... 166 11.4.5 SWOT Analysis .......................................................................................... 167 11.5Bio-Rad Laboratories, Inc. ............................................................................ 168 7 All rights reserved at BIS Research Inc.

  8. 11.5.1 Company Overview ................................................................................... 168 11.5.2 Role of Bio-Rad Laboratories, Inc. in the Global Epigenetics Market .............................................................................................................. 168 11.5.3 Financials ................................................................................................... 169 11.5.4 Key Insights About Financial Health of the Company ........................... 171 11.5.5 SWOT Analysis .......................................................................................... 172 11.6Illumina, Inc. ................................................................................................... 173 11.6.1 Company Overview ................................................................................... 173 11.6.2 Role of Illumina, Inc. in the Global Epigenetics Market ......................... 173 11.6.3 Financials ................................................................................................... 174 11.6.4 Key Insights About Financial Health of the Company ........................... 176 11.6.5 SWOT Analysis .......................................................................................... 177 11.7PerkinElmer Inc. ............................................................................................. 178 11.7.1 Company Overview ................................................................................... 178 11.7.2 Role of PerkinElmer Inc. in the Global Epigenetics Market ................... 178 11.7.3 Financials ................................................................................................... 179 11.7.4 Key Insights About Financial Health of the Company ........................... 182 11.7.5 SWOT Analysis .......................................................................................... 183 11.8Exact Sciences Corporation ......................................................................... 184 11.8.1 Company Overview ................................................................................... 184 11.8.2 Role of Exact Sciences Corporation in the Global Epigenetics Market ................................................................................................... 184 11.8.3 Financials ................................................................................................... 186 11.8.4 Key Insights About Financial Health of the Company ........................... 188 11.8.5 SWOT Analysis .......................................................................................... 189 11.9Merck KGaA ................................................................................................... 190 11.9.1 Company Overview ................................................................................... 190 Epigenetics Market 11.9.2 Role of Merck KGaA in the Global Epigenetics Market .......................... 190 11.9.3 Financials ................................................................................................... 191 11.9.4 Key Insights About Financial Health of the Company ........................... 193 8 All rights reserved at BIS Research Inc.

  9. 11.9.5 SWOT Analysis .......................................................................................... 194 11.10MDxHealth ...................................................................................................... 195 11.10.1Company Overview ................................................................................... 195 11.10.2Role of MDxHealth in the Global Epigenetics Market ............................. 195 11.10.3Financials ................................................................................................... 197 11.10.4Key Insights About Financial Health of the Company ........................... 199 11.10.5SWOT Analysis .......................................................................................... 200 11.11Agilent Technologies, Inc. ............................................................................ 201 11.11.1Company Overview ................................................................................... 201 11.11.2Role of Agilent Technologies, Inc. in the Global Epigenetics Market .............................................................................................................. 201 11.11.3Financials ................................................................................................... 202 11.11.4Key Insights About Financial Health of the Company ........................... 205 11.11.5SWOT Analysis .......................................................................................... 206 11.12Abcam Plc ...................................................................................................... 207 11.12.1Company Overview ................................................................................... 207 11.12.2Role of Abcam Plc in the Global Epigenetics Market ............................. 207 11.12.3Financials ................................................................................................... 208 11.12.4SWOT Analysis .......................................................................................... 210 11.13Pacific Biosciences of California, Inc. ......................................................... 211 11.13.1Company Overview ................................................................................... 211 11.13.2Role of Pacific Biosciences of California, Inc. in the Global Epigenetics Market.............................................................................. 211 11.13.3Financials ................................................................................................... 213 11.13.4Key Insights About Financial Health of the Company ........................... 215 11.13.5SWOT Analysis .......................................................................................... 216 11.14Zymo Research Corporation ......................................................................... 217 Epigenetics Market 11.14.1Company Overview ................................................................................... 217 11.14.2Role of Zymo Research Corporation in the Global Epigenetics Market ................................................................................................... 217 9 All rights reserved at BIS Research Inc.

  10. 11.14.3SWOT Analysis .......................................................................................... 219 11.15Active Motif, Inc. ............................................................................................ 220 11.15.1Company Overview ................................................................................... 220 11.15.2Role of Active Motif, Inc. in the Global Epigenetics Market ................... 220 11.15.3SWOT Analysis .......................................................................................... 222 11.16Promega Corporation .................................................................................... 223 11.16.1Company Overview ................................................................................... 223 11.16.2Role of Promega Corporation in the Global Epigenetics Market .......... 223 11.16.3SWOT Analysis .......................................................................................... 224 Epigenetics Market 10 All rights reserved at BIS Research Inc.

  11. List of Figures Figure 1: Figure 2: Global Cancer Burden-2020 Impact Analysis of Market Drivers and Market Challenges on the Global Epigenetics Market Global Epigenetics Market (by Product), $Million, 2020 and 2031 Global Epigenetics Market (by Mechanism), $Million, 2020 and 2031 Global Epigenetics Market (by Technology), $Million, 2020 and 2031 Global Epigenetics Market (by Application), $Million, 2020 and 2031 Global Epigenetics Market Snapshot Global Epigenetics Market: Research Methodology Primary Research Methodology Bottom-Up Approach (Segment-Wise Analysis) Top-Down Approach (Segment-Wise Analysis) Global Epigenetics Market Segmentation Global Epigenetics Market, $Million, 2020-2031 Global Epigenetics Market: COVID-19 Impact Analysis Global Cancer Burden-2020 Share of Key Developments and Strategies, January 2017-October 2021 Share of Synergistic Activities (by Company), January 2017-October 2021 Number of Product Launches (by Company), January 2017-October 2021 Share of Product Approvals (by Company), January 2017- October 2021 Share of Mergers and Acquisitions (by Company), January 2017– October 2021 Share of Other Business Activities (by Company), January 2017-October 2021 Market Share Analysis for Global Epigenetics Market, $Million, 2019 and 2020 Growth Share Analysis for Global Epigenetics Market (by Company), 2020 Growth Share Analysis for Global Epigenetics Market (by Technology), 2020-2031 Global Epigenetics Market (by Product) Global Epigenetics Market (by Product), $Million, 2020 and 2031 Global Epigenetics Market (Consumables), $Million, 2020-2031 Global Epigenetics Market (Kits and Assays), $Million, 2020-2031 Global Epigenetics Market (Reagents and Enzymes), $Million, 2020-2031 Global Epigenetics Market (Other Consumables), $Million, 2020-2031 Global Epigenetics Market (Instruments), $Million, 2020-2031 Global Epigenetics Market (Software), $Million, 2020-2031 Global Epigenetics Market (Mechanism) Global Epigenetics Market (Mechanism), $Million, 2020 and 2031 Global Epigenetics Market (DNA Methylation), $Million, 2020-2031 Global Epigenetics Market (Histone Modification), $Million, 2020-2031 Figure 3: Figure 4: Figure 5: Figure 6: Figure 7: Figure 8: Figure 9: Figure 10: Figure 11: Figure 12: Figure 13: Figure 14: Figure 15: Figure 16: Figure 17: Figure 18: Figure 19: Figure 20: Figure 21: Figure 22: Figure 23: Figure 24: Figure 25: Figure 26: Figure 27: Figure 28: Figure 29: Figure 30: Figure 31: Figure 32: Figure 33: Figure 34: Figure 35: Figure 36: Epigenetics Market 11 All rights reserved at BIS Research Inc.

  12. Figure 37: Figure 38: Figure 39: Figure 40: Figure 41: Figure 42: Figure 43: Figure 44: Figure 45: Figure 46: Figure 47: Figure 48: Figure 49: Figure 50: Figure 51: Figure 52: Figure 53: Figure 54: Global Epigenetics Market (RNA Modification), $Million, 2020-2031 Global Epigenetics Market (Other Mechanisms), $Million, 2020-2031 Global Epigenetics Market (by Technology) Global Epigenetics Market (by Technology), $Million, 2020 and 2031 Global Epigenetics Market (Polymerase Chain Reaction (PCR)), $Million, 2020-2031 Global Epigenetics Market (RT-PCR), $Million, 2020-2031 Global Epigenetics Market (dPCR), $Million, 2020-2031 Global Epigenetics Market (Sequencing), $Million, 2020-2031 Global Epigenetics Market (by Sequencing), $Million, 2020 and 2031 Global Epigenetics Market (NGS), $Million, 2020-2031 Global Epigenetics Market (Sanger Sequencing), $Million, 2020-2031 Global Epigenetics Market (Microarray), $Million, 2020-2031 Global Epigenetics Market (Other Technologies), $Million, 2020-2031 Global Epigenetics Market (by Application) Global Epigenetics Market (by Application), $Million, 2020 and 2031 Global Epigenetics Market (Oncology), $Million, 2020-2031 Global Epigenetics Market (Clinical Application in Oncology), $Million, 2020-2031 Global Epigenetics Market (Translational Research Application in Oncology), $Million, 2020-2031 Global Epigenetics Market (Metabolic Diseases), $Million, 2020-2031 Figure 55: Figure 56: Global Epigenetics Market (Clinical Application in Metabolic Diseases), $Million, 2020- 2031 Figure 57: Global Epigenetics Market (Translational Research Application in Metabolic Diseases), $Million, 2020-2031 Global Epigenetics Market (Immunology), $Million, 2020-2031 Global Epigenetics Market (Clinical Application in Immunology), $Million, 2020-2031 Figure 58: Figure 59: Figure 60: Global Epigenetics Market (Translational Research Application in Immunology), $Million, 2020-2031 Global Epigenetics Market (Cardiovascular Diseases), $Million, 2020-2031 Figure 61: Figure 62: Global Epigenetics Market (Clinical Application in Cardiovascular Diseases), $Million, 2020-2031 Figure 63: Global Epigenetics Market (Translational Research Application in Cardiovascular Diseases), $Million, 2020-2031 Global Epigenetics Market (Other Applications), $Million, 2020-2031 Global Epigenetics Market (Clinical Application in Other), $Million, 2020-2031 Global Epigenetics Market (Translational Research Application), $Million, 2020-2031 Global Epigenetics Market (by End User) Global Epigenetics Market (by End User), $Million, 2020 and 2031 Figure 64: Figure 65: Figure 66: Figure 67: Figure 68: Figure 69: Epigenetics Market Global Epigenetics Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2031 Global Epigenetics Market (Academic and Research Institutions), $Million, 2020-2031 Global Epigenetics Market (Contract Research Organizations), $Million, 2020-2031 Figure 70: Figure 71: 12 All rights reserved at BIS Research Inc.

  13. Figure 72: Figure 73: Figure 74: Figure 75: Figure 76: Figure 77: Figure 78: Figure 79: Figure 80: Figure 81: Figure 82: Figure 83: Figure 84: Figure 85: Figure 86: Figure 87: Figure 88: Figure 89: Figure 90: Figure 91: Figure 92: Figure 93: Figure 94: Figure 95: Figure 96: Figure 97: Figure 98: Figure 99: Figure 100: Figure 101: Figure 102: Figure 103: Figure 104: Figure 105: Figure 106: Figure 107: Figure 108: Figure 109: Figure 110: Global Epigenetics Market (Other End Users), $Million, 2020-2031 Global Epigenetics Market Snapshot (by Region), $Million, 2020-2031 Global Epigenetics Market (by Region), $Million, 2020-2031 Global Epigenetics Market (by Region), $Million, 2020 and 2031 North America Epigenetics Market, $Million, 2020-2031 North America: Market Dynamics North America Epigenetics Market (by Country), $Million, 2020-2031 U.S. Epigenetics Market, $Million, 2020-2031 Canada Epigenetics Market, $Million, 2020-2031 Europe Epigenetics Market, $Million, 2020-2031 Europe: Market Dynamics Europe Epigenetics Market (by Country), $Million, 2020-2031 Germany Epigenetics Market, $Million, 2020-2031 France Epigenetics Market, $Million, 2020-2031 U.K. Epigenetics Market, $Million, 2020-2031 Italy Epigenetics Market, $Million, 2020-2031 Spain Epigenetics Market, $Million, 2020-2031 Rest-of-Europe Epigenetics Market, $Million, 2020-2031 Asia-Pacific Epigenetics Market, $Million, 2020-2031 APAC: Market Dynamics APAC Epigenetics Market (by Country), $Million, 2020-2031 China Epigenetics Market, $Million, 2020-2031 India Epigenetics Market, $Million, 2020-2031 Japan Epigenetics Market, $Million, 2020-2031 South Korea Epigenetics Market, $Million, 2020-2031 Australia Epigenetics Market, $Million, 2020-2031 RoAPAC Epigenetics Market, $Million, 2020-2031 Latin America Epigenetics Market, $Million, 2020-2031 Latin America: Market Dynamics Global Epigenetics Market (by Country), $Million, 2020-2031 Brazil Epigenetics Market, $Million, 2020-2031 Mexico Epigenetics Market, $Million, 2020-2031 Rest-of-Latin America (RoLA) Epigenetics Market, $Million, 2020-2031 Rest-of-the-World (RoW) Epigenetics Market, $Million, 2020-2031 Total Number of Companies Profiled Thermo Fisher Scientific Inc.: Product Portfolio Thermo Fisher Scientific, Inc.: Overall Financials, $Million, 2018-2020 Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2018-2020 Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018-2020 Epigenetics Market 13 All rights reserved at BIS Research Inc.

  14. Figure 111: Figure 112: Figure 113: Figure 114: Figure 115: Figure 116: Figure 117: Figure 118: Figure 119: Figure 120: Figure 121: Figure 122: Figure 123: Figure 124: Figure 125: Figure 126: Figure 127: Figure 128: Figure 129: Figure 130: Figure 131: Figure 132: Figure 133: Figure 134: Figure 135: Figure 136: Figure 137: Figure 138: Figure 139: Figure 140: Figure 141: Figure 142: Figure 143: Figure 144: Figure 145: Figure 146: Figure 147: Figure 148: Figure 149: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020 Thermo Fisher Scientific Inc: SWOT Analysis QIAGEN N.V.: Product Portfolio QIAGEN N.V.: Overall Financials, $Million, 2018-2020 QIAGEN N.V.: Revenue (by Segment), $Million, 2018-2020 QIAGEN N.V.: Revenue (by Region), $Million, 2018-2020 QIAGEN N.V.: R&D Expenditure, $Million, 2018-2020 QIAGEN N.V.: SWOT Analysis F. Hoffmann-La Roche Ltd.: Product Portfolio F. Hoffmann-La Roche Ltd.: Overall Financials, $Million, 2018-2020 F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2018-2020 F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2018-2020 F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2018-2020 F. Hoffmann-La Roche Ltd: SWOT Analysis Bio-Rad Laboratories, Inc.: Product Portfolio Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2018-2020 Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2018-2020 Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2018-2020 Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2018-2020 Bio-Rad Laboratories, Inc.: SWOT Analysis Illumina Inc, Product Portfolio Illumina, Inc: Overall Financials, $Million, 2018-2020 Illumina, Inc. Revenue (by Segment), $Million, 2018-2020 Illumina, Inc.: Revenue (by Region), $Million, 2018-2020 Illumina, Inc: R&D Expenditure, $Million, 2018-2020 Illumina, Inc: SWOT Analysis PerkinElmer Inc.: Product Portfolio PerkinElmer Inc.: Overall Financials, $Million, 2018-2020 PerkinElmer Inc.: Revenue (by Segment), $Million, 2018-2020 PerkinElmer Inc.: Revenue (by Region), $Million, 2018-2020 PerkinElmer Inc.: R&D Expenditure, $Million, 2018-2020 PerkinElmer Inc.: SWOT Analysis Exact Sciences Corporation: Service Portfolio Exact Sciences Corporation: Overall Financials, $Million, 2018-2020 Exact Sciences Corporation: Revenue (by Segment), $Million, 2018-2020 Exact Sciences Corporation: Revenue (by Region), $Million, 2018-2020 Exact Sciences Corporation: R&D Expenditure, $Million, 2018-2020 Figure 14.19: Exact Sciences Corporation: SWOT Analysis Merck KGaA: Product Portfolio Epigenetics Market 14 All rights reserved at BIS Research Inc.

  15. Figure 150: Figure 151: Figure 152: Figure 153: Figure 154: Figure 155: Figure 156: Figure 157: Figure 158: Figure 159: Figure 160: Figure 161: Figure 162: Figure 163: Figure 164: Figure 165: Figure 166: Figure 167: Figure 168: Figure 169: Figure 170: Figure 171: Figure 172: Figure 173: Figure 174: Figure 175: Figure 176: Figure 177: Figure 178: Figure 179: Figure 180: Figure 181: Figure 182: Merck KGaA: Overall Financials, $Million, 2018-2020 Merck KGaA: Revenue (by Segment), $Million, 2018-2020 Merck KGaA: Revenue (by Region), $Million, 2018-2020 Merck KGaA: R&D Expenditure, $Million, 2018-2020 Merck KGaA: SWOT Analysis MDxHealth: Service Portfolio MDxHealth: Overall Financials, $Million, 2018-2020 MDxHealth: Revenue (by Segment), $Million, 2018-2020 MDxHealth: Revenue (by Region), $Million, 2018-2020 MDxHealth: R&D Expenditure, $Million, 2018-2020 MDxHealth: SWOT Analysis Agilent Technologies, Inc.: Product Portfolio Agilent Technologies, Inc.: Overall Financials, $Million, 2018-2020 Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2018-2020 Agilent Technologies, Inc.: Revenue (by Region), $Million, 2018-2020 Agilent Technologies, Inc.: R&D Expenditure, $Million, 2018-2020 Agilent Technologies, Inc.: SWOT Analysis Abcam Plc: Service Portfolio Abcam Plc: Overall Financials, $Million, 2018-2020 Abcam Plc: Revenue (by Region), $Million, 2018-2020 Abcam Plc: SWOT Analysis Pacific Biosciences of California, Inc. Product Portfolio Pacific Biosciences of California, Inc.: Overall Financials, $Million, 2018-2020 Pacific Biosciences of California, Inc.: Revenue (by Segment), $Million, 2018-2020 Pacific Biosciences of California, Inc.: Revenue (by Region), $Million, 2018-2020 Pacific Biosciences of California, Inc.: R&D Expenditure, $Million, 2018-2020 Pacific Biosciences of California, Inc.: SWOT Analysis Zymo Research Corporation: Product Portfolio Zymo Research Corporation: SWOT Analysis Active Motif, Inc.: Product Portfolio Active Motif, Inc.: SWOT Analysis Promega Corporation.: Product Portfolio Promega Corporation Inc., SWOT Analysis Epigenetics Market 15 All rights reserved at BIS Research Inc.

  16. List of Tables Table 1: Table 2: Table 3: Table 4: Table 5: Table 6: Table 7: Table 8: Table 9: Table 10: Table 11: Table 12: Table 13: Key Coverage Providers for Epigenetics Tests Likert Scale Impact Analysis of Market Drivers Impact Analysis of Market Restraints Products and Prices Companies Providing Kits and Assays Companies Offering Reagents and Enzymes Companies Offering Other Consumables Companies Offering Instruments Companies Offering Software RT-PCR-Based Epigenetics Products dPCR-Based Epigenetics Products NGS-Based Epigenetics Products Epigenetics Market 16 All rights reserved at BIS Research Inc.

  17. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies. For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 Epigenetics Market 17 All rights reserved at BIS Research Inc.

  18. BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Epigenetics Market Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 18 www.bisresearch.com All rights reserved at BIS Research Inc.

More Related